A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.
Dotan, Iris; Rachmilewitz, Daniel; Schreiber, Stefan; Eliakim, Rami; Van der Woude, C. Janneke; Kornbluth, Asher; Buchman, Alan L.; Bar-Meir, Shimon; Bokemeyer, Bernd; Goldin, Eran; Maaser, Christian; Mahadevan, Uma; Seidler, Ursula; Hoffman, Jörg C.; Homoky, Douglas; Plasse, Terry; Powers, Barbara; Rutgeerts, Paul; Hommes, Daniel; Gut, 2010, vol. 59, issue 6, p 11, ISSN 00175749. ISBN 14683288.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef